BMC (BioMed Central)

Molecular and Cellular Therapies Template

Write in a clean editor, then format for Molecular and Cellular Therapies in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Molecular and Cellular Therapies format

Molecular and Cellular Therapies is a peer-reviewed journal published by BMC (BioMed Central), covering RNA Interference and Gene Delivery, MicroRNA in disease regulation, HIV Research and Treatment.

PublisherBMC (BioMed Central)
Reference styleNumbered (Vancouver)
Numbered — [1], [2] in the text
1. Smith A, Jones B, Lee C. A representative article title. Molecular and Cellular Therapies. 2023;12(3):45–58.

Formats any DOI in Molecular and Cellular Therapies style. No sign-up.

Publishes research inRNA Interference and Gene Delivery MicroRNA in disease regulation HIV Research and Treatment Pluripotent Stem Cells Research CAR-T cell therapy research
ISSN2052-8426
h-index28
i10-index40
Total citations2,987
Top institutions publishing hereAarhus University
Journal websitejournals.riverpublishers.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Molecular and Cellular Therapies per year

6
2013
35
2014
8
2015
3
2016
2
2017
6
2018

Citation impact of Molecular and Cellular Therapies by publication year

70
2013
1.5K
2014
603
2015
757
2016
2
2017
10
2018

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Molecular and Cellular Therapies

Albumin-based drug delivery: harnessing nature to cure disease

Maja Thim Larsen, Matthias Kuhlmann, Michael Lykke Hvam et al. · 27 Feb 2016

The effectiveness of a drug is dependent on accumulation at the site of action at therapeutic levels, however, challenges such as rapid renal clearance, degradation or non-specific accumulation requires drug delivery enabling technologies. Albumin is a natural transport protein with multiple ligand binding sites, cellular receptor engagement, and a long circulatory half-life due to interaction…

Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets

Roshan Fatima, Vijay Suresh Akhade, Debosree Pal et al. · 12 Jun 2015

Long noncoding RNAs are emerging as key players in various fundamental biological processes. We highlight the varied molecular mechanisms by which lncRNAs modulate gene expression in diverse cellular contexts and their role in early mammalian development in this review. Furthermore, it is being increasingly recognized that altered expression of lncRNAs is specifically associated with tumorigenesis,…

Gene therapy for cancer: present status and future perspective

Magid H. Amer · 1 Jan 2014

Advancements in human genomics over the last two decades have shown that cancer is mediated by somatic aberration in the host genome. This discovery has incited enthusiasm among cancer researchers; many now use therapeutic approaches in genetic manipulation to improve cancer regression and find a potential cure for the disease. Such gene therapy includes transferring…

Targeting the Wnt pathways for therapies

Artem Blagodatski, Dmitry Poteryaev, Vladimir L. Katanaev · 1 Jan 2014

The Wnt/β-catenin signaling pathway is crucial in animal development from sponges to humans. Its activity in the adulthood is less general, with exceptions having huge medical importance. Namely, improper activation of this pathway is carcinogenic in many tissues, most notably in the colon, liver and the breast. On the other hand, the Wnt/β-catenin signaling must…

Outlook on PI3K/AKT/mTOR inhibition in acute leukemia

Lars Fransecky, Liliana H. Mochmann, Claudia D. Baldus · 19 Mar 2015

Technological advances allowing high throughput analyses across numerous cancer tissues have allowed much progress in understanding complex cellular signaling. In the future, the genetic landscape in cancer may have more clinical relevance than diagnosis based on tumor origin. This progress has emphasized PI3K/AKT/mTOR, among others, as a central signaling center of cancer development due to…

Molecular and Cellular Therapies template — frequently asked questions

How do I write a paper in the Molecular and Cellular Therapies format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Molecular and Cellular Therapies template. When you export, DocuGuru compiles the paper into the official BMC (BioMed Central) format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Molecular and Cellular Therapies use?
Molecular and Cellular Therapies uses Numbered (Vancouver) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith A, Jones B, Lee C. A representative article title. Molecular and Cellular Therapies. 2023;12(3):45–58.
Do I need to know LaTeX to submit to Molecular and Cellular Therapies?
No. DocuGuru generates the bmcart LaTeX class and compiles the PDF for you in the background, so you get a BMC (BioMed Central)-ready Molecular and Cellular Therapies document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Molecular and Cellular Therapies template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Molecular and Cellular Therapies format with correct headings, figures, tables, and numbered citations.
Who publishes Molecular and Cellular Therapies?
Molecular and Cellular Therapies is a life sciences and medicine journal published by BMC (BioMed Central). DocuGuru's Molecular and Cellular Therapies template matches BMC (BioMed Central)'s official submission format.
Can I export a submission-ready Molecular and Cellular Therapies PDF?
Yes — DocuGuru produces a PDF built with the official Molecular and Cellular Therapies template (the bmcart class) that is ready to submit to BMC (BioMed Central), together with the matching LaTeX source files.
How much does the Molecular and Cellular Therapies template cost?
You can start writing in the Molecular and Cellular Therapies template for free. Exporting the final submission-ready Molecular and Cellular Therapies PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Molecular and Cellular Therapies template